688136 科兴制药
2023/09 - 九个月2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)-3.043-4.8565.15711.01426.841
总资产报酬率 ROA (%)-1.715-3.0163.7137.84615.711
投入资产回报率 ROIC (%)-1.875-3.3454.1258.92419.672

边际利润分析
销售毛利率 (%)71.51275.36579.41079.98381.528
营业利润率 (%)-7.484-10.5307.62613.09915.871
息税前利润/营业总收入 (%)-5.363-9.4347.83214.76316.750
净利润/营业总收入 (%)-5.999-7.0547.50611.40213.421

收益指标分析
经营活动净收益/利润总额(%)137.544100.52938.389101.015105.064
价值变动净收益/利润总额(%)-33.8052.28259.2400.0000.000
营业外收支净额/利润总额(%)3.1370.363-2.483-0.436-0.641

偿债能力分析
流动比率 (X)1.7312.6172.4203.7301.472
速动比率 (X)1.4902.2312.1353.4731.158
资产负债率 (%)44.37042.83032.46122.66940.989
带息债务/全部投入资本 (%)38.39835.86022.33314.82724.455
股东权益/带息债务 (%)157.051175.534338.666573.941294.268
股东权益/负债合计 (%)124.938133.669208.059341.125143.971
利息保障倍数 (X)-2.270-8.31820.0228.58217.097

营运能力分析
应收账款周转天数 (天)92.51192.14496.75696.86382.294
存货周转天数 (天)185.076211.192194.229185.425182.902